ArticleProceedings of the National Academy of Sciences of the United States of America2022

Inflammatory response to retrotransposons drives tumor drug resistance that can be prevented by reverse transcriptase inhibitors.

Ksenia A Novototskaya-Vlasova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.